The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Secretase

Secretase

Secretase refers to a group of enzymes that cleave proteins, playing a crucial role in various biological processes.
These proteolytic enzymes are involved in the proteolytic processing of amyloid precursor protein, which is implicated in the pathogenesis of Alzheimer's disease.
Secretase research is vital for understanding disease mechanisms and developing targeted therapies.
PubComapre.ai optimizes this research by leveraging AI-driven protocol comparisons to locate the best Secretase protocols from literature, preprints, and patents, enhancing reproducibility and accuracy.
Experince seamless Secretase research with the power of PubComapre.ai.

Most cited protocols related to «Secretase»

All data sets were recorded using 300 keV electrons. The γ-secretase, β-galactosidase, and mitoribosome data sets were recorded manually; the complex-I data set was recorded automatically using the EPU software from FEI. For all data sets, fields of views that showed signs of significant drift, charging, or astigmatism were discarded. For the γ-secretase data, this assessment was made after alignment using the algorithm by Li et al. (2013) (link). Movies on the Falcon-II detectors on the Polara and Titan Krios microscopes were intercepted using a system that was developed in-house (Bai et al., 2013 (link)). CTF parameters were estimated using CTFFIND3 (Mindell and Grigorieff, 2003 (link)), and the particles were picked in a semi-automated manner, using EMAN2 (Tang et al., 2007 (link)) for the mitoribosome, and RELION for the three other data sets. Selection of particles for the final 3D reconstruction was performed using reference-free 2D class averaging and 3D classification in RELION (Scheres, 2012 (link)), and the final maps before and after movie processing were calculated using RELION’s 3D auto-refine, followed by automated B-factor sharpening (Rosenthal and Henderson, 2003 (link)) and correction for the MTF of the detector. All resolutions were based on the gold-standard FSC = 0.143 criterion (Scheres and Chen, 2012 (link)), and FSC curves were corrected for the effects of soft masking by high-resolution noise substitution (Chen et al., 2013 (link)). Density figures were made using UCSF Chimera (Pettersen et al., 2004 (link)).
Full text: Click here
Publication 2014
Astigmatism beta-Galactosidase Chimera Complement Factor B Electrons Gold Microscopy Microtubule-Associated Proteins Mitochondrial Ribosomes NADH Dehydrogenase Complex 1 Reconstructive Surgical Procedures Secretase
Unfiltered reconstructions for TRPV1 (EMD-5778), γ-secretase (EMD-3061) and β-galactosidase (EMD-2984) were obtained from the EMDB model challenge website (http://challenges.emdatabank.org). Initial map targets for coordinate refinement were generated by applying uniform filtering to the original EMDB entries. The deposited map for TRPV1 (EMD-5778) was globally sharpened using an additional B-factor of −100 Å2. Coordinate refinement was performed using real-space refinement against the initial map as implemented in cctbx/PHENIX (Adams et al., 2010 (link)) with additional restraints on secondary structure. Residue-grouped atomic B-factors were refined in reciprocal space. For TRPV1 and β-galactosidase, non-crystallography symmetry (NCS) restraints were employed to account for rotational and dihedral symmetry. Reference restraints for PETG were obtained with phenix.elbow from the crystal structure of 2-phenylethyl 1-thio-β-D-galactopyranoside (Brito et al., 2011 (link)). Building of glycans used glycan modeling tools available in Coot. Local resolution for all maps was estimated by local FSC computations using an in-house Python program locres.py. Local resolution mapped to the coordinate models using the measure_mapValues function in UCSF Chimera (Pettersen et al., 2004 (link)), and the residue-averaged resolution was used to assign local resolution-scaled reference restraints. Model rebuilding was performed in Coot (Emsley and Cowtan, 2004 (link)). Half-set reconstructions for cross validation were obtained from the EMDB model challenge. Model maps were generated by inverse Fourier transform using B-factor-weighted electron form factors (Colliex et al., 2006 ). The FSCref between model map and half-set 3D reconstructions was used to assess over-fitting. To this end, coordinates were first refined against the full map. Coordinates were then randomly displaced by a maximum of 0.5 Å and subjected to three cycles of real-space refinement against one of the half maps (work map) using the same protocol outlined above. The other half map (test map) was used as the test map for cross-validation. Following refinement, we computed the FSC of the refined model against the work map (FSCwork) and the cross-validated FSC between refined model and the test map (FSCtest). All FSCs were computed using a structure mask obtained from the respective EMDB entry that was low-passed filtered to 60 Å.
To compare model refinement against deposited EMDB entries and LocScale maps, PDB-deposited coordinate models associated with the respective EMDB entry were randomly perturbed by applying atom shifts of up to 0.4 Å to serve as starting models. Five iterations of local and global real-space coordinate refinement against the respective EMDB or LocScale map were each followed by refinement of atomic B-factors in reciprocal space. As above, secondary structure restraints, resolution-dependent weights and NCS restraints were employed. EMRinger scores were computed using phenix.em_ringer (Barad et al., 2015 (link)); all other validation scores were obtained using MOLPROBITY (Chen et al., 2010 (link)). All cross-validation FSC and real-space correlations were computed against the original reconstruction and the deposited EMDB map, respectively.
Full text: Click here
Publication 2017
Chimera Complement Factor B Crystallography Elbow Electrons Galactose GLB1 protein, human Microtubule-Associated Proteins phenylethylthio-beta-galactopyranoside Polysaccharides Python Reconstructive Surgical Procedures Secretase Seizures
[18F]AV-45 was studied in a total of 16 HC volunteers and 16 AD patients. Patients with AD had to be greater than 50 years of age and have a probable diagnosis of AD according to the NINCDS-ADRDA, with a Mini-Mental State Examination (MMSE) score between 10 and 24 inclusive. (12 (link), 13 (link)) HC subjects had to be greater than 50 years of age, with no evidence of cognitive impairment by history and psychometric testing, and had to have an MMSE score of ≥ 29. Subjects who showed evidence of any other significant neurodegenerative or psychiatric disease on clinical examination or MRI, or clinically significant medical comorbidities that might pose a safety risk to the subject or interfere with interpretation of the scan were excluded from the study. Patients with AD could be on a stable dose (by investigator judgment: not in titration period, no change in medication being considered) of an acetylcholinesterase inhibitor, memantine, and/or Vitamin E. Patients who had ever participated in an experimental study with a treatment targeting amyloid (e.g., immunotherapy, secretase inhibitor, selective amyloid lowering agents) were excluded. All procedures were approved by the appropriate Institutional Review Board and all participants or an appropriate representative signed informed consent forms, consistent with established criteria (12 (link)).
Similar acquisition protocols were used at the three centers. All subjects received a single IV bolus of approximately 370 MBq or 10 mCi [18F]AV-45 and PET imaging began. Dynamic brain PET images were collected for a period of approximately 90 minutes. The PET scanners employed were GE Advance (PET only, at JHU), GE Discovery LS (PET/CT), at CHC and MEC, and the Discovery ST (PET/CT), at MEC). In addition plasma metabolite analysis was conducted using the method of Hilton, et al (14 (link)). For detailed PET, metabolite analysis and image acquisition procedures see supplementary information.
Publication 2010
Acetylcholinesterase Inhibitors APP protein, human Brain Diagnosis Disorders, Cognitive Ethics Committees, Research Immunotherapy Inclusion Bodies Memantine Mental Disorders Mini Mental State Examination Patients Pharmaceutical Preparations Physical Examination Plasma Radionuclide Imaging Safety Scan, CT PET Secretase Titrimetry Vitamin E Voluntary Workers
For lineage analysis in the intestine, four week-old mice, including control mice, received one single intra-peritoneal injection of tamoxifen (ICN) (50 or 5 mg/Kg of mouse body weight) and were analyzed at the indicated chase time points. To confirm the absence of leakiness of the new transgenic lines, we analyzed Notch(1–2)-CreERT2SAT/+; R26R/+ and N(1–2)-CreERT2SAT/+; R26mTmG/+ mice without tamoxifen administration and found no LacZ nor GFP staining in these control mice. For expression analysis in other organs we used a single intra-peritoneal injection of 4-Hydroxytamoxifen (4-OHT) (50 mg/kg of mouse body weight).
Pharmacological inhibition of Notch signaling in Hes1-EmGFPSAT mice was achieved by intraperitoneal administration of the γ-secretase inhibitor dibenzazepine (DBZ: 20 µM/kg body weight in 0.5% HPMC, 0.1% w/v NP40 in water; Calbiochem). Adult mice were injected with DBZ for 4 consecutive days and analyzed 3–4 days after the last injection.
Full text: Click here
Publication 2011
4,17 beta-dihydroxy-4-androstene-3-one Adult Animals, Transgenic Body Weight dibenzazepine hydroxytamoxifen Injections, Intraperitoneal Intestines LacZ Genes Mice, Laboratory NOTCH2 protein, human Psychological Inhibition Secretase Tamoxifen
Cell culture media were from GIBCO BRL. TOPRO-3 and phalloidin-Alexa 568 (Molecular Probes, Inc.) were used to label nuclei and actin. MDC was from Sigma-Aldrich. γ-Secretase inhibitors were from Calbiochem (X or L685,458), Elan (DAPT), and AstraZeneca (Compound C).
Polyclonal anti-PS1-NTF (B19.2), -CTF (B32.1) and -TLN (B36.1) have been described previously (Annaert et al., 2001 (link)). B63.1 and B59.1 were generated using a synthetic peptide mimicking the final 16 and 18 amino acids of APP and nicastrin, respectively, coupled to KLH (Pierce Chemical Co.). Mab 9C3 against nicastrin was produced by immunizing the same peptide in balb/c mice followed by generation of a hybridoma cell line according to established procedures. We acknowledge the antibody gifts of anti-calnexin (A. Helenius, ETH Zurich, Zurich, Switzerland), anti-ergic-53 (J. Saraste, University of Bergen, Bergen, Norway) -LC3 (T. Yoshimori, National Institute of Genetics, Shizuoka-ken, Japan), -Apg12 (N. Mizushima, National Institute for Basic Biology, Okazaki, Japan), PIP2 (G. Hammond, Cancer Research Institute, London, UK), -LBPA (J. Gruenberg, University of Geneva, Geneva, Switzerland), and -APP COOH terminus (c 1/6.1; P. Mathews, Nathan Kline Institute, Orangeburg, NY). Mabs to Lamp-2 (Abl-93) were obtained from Developmental Studies Hybridoma Bank (Iowa City, Iowa); anti-synaptophysin (cl.7.2) and anti-PS1-CTF (mAb 5.2) were from R. Jahn (MPI-Göttingen, Göttingen, Germany) and B. Cordell (Scios Inc., Sunnyvale, CA). mAbs to GM130 and EEA1 were from BD Biosciences, the transferrin receptor from Zymed Laboratories, β-COP from Sigma-Aldrich, and BIP from StressGen Biotechnologies.
Publication 2004
1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol 2-amino-5-phosphopentanoic acid Actins alexa 568 anti-synaptophysin Antibodies, Anti-Idiotypic Calnexin Cell Culture Techniques Cell Lines Cell Nucleus Cells Culture Media Gifts Hybridomas inhibitors LAMP2 protein, human Malignant Neoplasms Mice, Inbred BALB C Molecular Probes Monoclonal Antibodies Peptides Phalloidine Secretase Transferrin Receptor

Most recents protocols related to «Secretase»

Not available on PMC !

Example 1

We demonstrated the expression of STAT1 was higher in AD cases than the aged matched control cases (FIGS. 1A and 1B). In FIG. 1A, no staining of Phosphorylated STAT1 (pSTAT1) was seen in the control cells. In contrast, as shown in the same FIG. 1A and the enlarged snapshot of the photo of Case-1 in FIG. 1B, much more staining of pSTAT1 was seen in each of the three cases.

To understand whether the activation of STAT1 pathway was causal for the pathogenesis of AD, or was an consequence of neuro-inflammation in late stage of AD, we crossed STAT1−/− mice with APP/PS1 mice to generate AD mice with STAT1−/− background. APP/PS1/STAT1−/− mice, and their littermate controls of APP/PS1 genotype were kept to 3-4 months and sacrificed for histological examination of Aβ deposition. Surprisingly, we found consistent reduction in Aβ number as well as areas occupied by Aβ in Stat1−/− mice (FIGS. 2A and 2B), Similar results were observed when we measure Aβ42 in TBS or formic acid extraction (FIGS. 2C and 2D). Furthermore, the reduction in Aβ was not due to change in APP expression level, or the secretase cleavages APP (FIGS. 16A and 16B).

Full text: Click here
Patent 2024
Cells Cytokinesis Figs formic acid Genotype Inflammation Mice, House Mice, Knockout Mice, Laboratory pathogenesis Secretase STAT1 protein, human Vision

Example 4

Multiple mechanism could contribute to the increase of cellular APP following 25-OHC treatment. However, our mouse data suggested both the synthesis and degradation of APP were normal: the expression of APP was similar, and the enzymes for APP cleavage was also comparable (FIGS. 16A and 16B). As shown in FIG. 16A, the expression level of APP was similar regardless of STAT1 deficiency. As shown in FIG. 16B, the expression level of Adam10, BACE1 and Nicastrin, i.e., the α, β, and γ secretase of APP, respectively were also similar regardless of STAT1 deficiency.

We went on to check the trafficking of APP protein. Surface APP were labeled by antibody, and cells were put back to incubator and fixed at different time point for staining. In untreated cells, APP quickly went to specific compartment in the cell, and within 6 hours, the signal disappeared, while in the 25-OHC treated cells, the trafficking of APP was slower (FIG. 10A). Timelapse movie showed clearly in untreated cells, APP cluster to specific compartment while in 25-OHC treated cells, APP were still evenly distributed within the time of examination (FIG. 10B).

Full text: Click here
Patent 2024
Anabolism BACE1 protein, human Cells Cytokinesis Enzymes Immunoglobulins Mus Retention (Psychology) Secretase STAT1 protein, human
Human mammary immortalized cells (MCF10A), and the TNBC cell line MDA-MB-231 were purchased from American Type Culture Collection. MCF10A cells were grown in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium with 20 ng mL−1 human epidermal growth factor, 100 ng mL−1 cholera toxin, 0.01 mg mL−1 bovine insulin, 500 ng mL−1 hydrocortisone, and 5% horse serum. MDA-MB-231 cells were grown in DMEM containing L-glutamine and sodium pyruvate, supplemented with 10% fetal bovine serum and 1% antibiotic and antimycotic solution in a humidified atmosphere of 5% CO2 at 37°C in an incubator. Human BCSC cells: ALDH+ and CD44+/CD24, and BC cells: ALDH- were purchased from Celprogen (San Pedro, CA, United States) and maintained in human BCSC expansion and undifferentiation media. DAPT (γ-secretase), cycloheximide (CHX), chloroquine (CQ), and MG132 were purchased from Sigma (St. Louis, MO).
Full text: Click here
Publication 2023
1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol Antibiotics Atmosphere Bos taurus Breast CD44 protein, human Cell Culture Techniques Cell Lines Cells Chloroquine Cholera Toxin Cycloheximide Eagle Epidermal growth factor Equus caballus Fetal Bovine Serum Glutamine Homo sapiens Hydrocortisone Insulin MDA-MB-231 Cells MG 132 Pyruvate Secretase Serum Sodium
The assay was performed in a 96-well flat-bottom white plate using β-Secretase Activity Fluorometric Assay Kit (Biovision, CA, USA). To begin, HT22 cells were treated with HYP (20–80 μM) for 24 h and then collected by centrifugation with ice-cold extraction buffer added for homogenization. After centrifugation, 50 μL supernatant (cell lysate) was transferred to each well in the 96-well plate. 2 μL of active β-secretase (protein concentration: 4 μg/μL) was added to the 50 μL of extraction buffer as the positive control. For negative control, 2 μL of the β-secretase inhibitor was added to the 50 μL of sample well. 2 μL of each of the tested samples were added into each sample well for inhibitory activity evaluation. Following compounds addition, 50 μL of 2X reaction buffer was added with a gentle mix and incubation for 20 min at 37 °C before adding 2 μL of the β-secretase substrate. The plate was then covered and incubated in the dark at 37 °C for 1 h. Samples were then measured in a fluorescent 96-well plate reader (Ex/Em = 345/500 nm). Background readings produced from the substrate without adding secretase were subtracted from all samples.
Full text: Click here
Publication 2023
Biological Assay Buffers Cells Centrifugation Cold Temperature Fluorometry Proteins Psychological Inhibition Secretase
Accessible from the RCSB protein data bank (PDB) (https://www.rcsb.org/2AYD) are three-dimensional tertiary structures of the β-Secretase protein for study. The structure was imported using a freely available molecular editor (Discovery studio visualizer 4.0). Co-crystal ligands and heteroatoms were deleted before the structure was saved in .pdb format. The Chimera UCSF team employed a thousand-step steepest-descent and a thousand-step Conjugate gradient of energy minimization approach for this optimization. Curcumin (Chem I. D: 92158) was downloaded (https://pubchem.ncbi.nlm.nih.gov/compound/Lupenone; accessed on: 12 January 2023 ) as a .sdf file from PubChem. These .pdb files result from a ligand structure loaded into the Discovery Studio visualizer.
Full text: Click here
Publication 2023
Chimera Curcumin Ligands lupenone Secretase STEEP1 protein, human

Top products related to «Secretase»

Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States
The β-secretase activity kit is a laboratory tool used to measure the enzymatic activity of β-secretase, a key enzyme involved in the production of amyloid-β peptides. The kit provides the necessary reagents and protocols to quantify β-secretase activity in cell lysates or other biological samples.
Sourced in United States, Germany, Belgium
N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) is a chemical compound used in research. It functions as a gamma-secretase inhibitor.
Sourced in United States
The SensoLyte 520 TACE (α-secretase) activity assay kit is a fluorometric assay designed to detect and measure the activity of TACE (Tumor Necrosis Factor-α Converting Enzyme), also known as ADAM17 (A Disintegrin and Metalloproteinase domain-containing protein 17). The assay utilizes a specific TACE substrate labeled with a fluorophore and a quencher. Upon cleavage of the substrate by TACE, the fluorophore is released, resulting in an increase in fluorescence signal that can be measured.
Sourced in United States, China, United Kingdom, Germany, France, Australia, Canada, Japan, Italy, Switzerland, Belgium, Austria, Spain, Israel, New Zealand, Ireland, Denmark, India, Poland, Sweden, Argentina, Netherlands, Brazil, Macao, Singapore, Sao Tome and Principe, Cameroon, Hong Kong, Portugal, Morocco, Hungary, Finland, Puerto Rico, Holy See (Vatican City State), Gabon, Bulgaria, Norway, Jamaica
DMEM (Dulbecco's Modified Eagle's Medium) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types, including mammalian cells. It provides essential nutrients, amino acids, vitamins, and other components necessary for cell proliferation and survival in an in vitro environment.
Sourced in United States, Germany, United Kingdom, Japan, Italy, Canada, Spain, France, Switzerland, China, Australia, Israel, Denmark, Ireland, Sweden, Austria
Neurobasal medium is a cell culture medium designed for the maintenance and growth of primary neuronal cells. It provides a defined, serum-free environment that supports the survival and differentiation of neurons. The medium is optimized to maintain the phenotypic characteristics of neurons and minimizes the growth of non-neuronal cells.
Sourced in United States, Germany, United Kingdom, Canada, China, Italy, Switzerland, Israel, Sao Tome and Principe, France, Austria, Macao, Japan, India, Belgium, Denmark
Laminin is a protein component found in the extracellular matrix of cells. It plays a key role in cell attachment, differentiation, and migration processes.
Sourced in United States
LY411575 is a small molecule compound that inhibits the Notch signaling pathway by selectively inhibiting the gamma-secretase enzyme complex. It is commonly used as a research tool in cell biology and developmental biology studies.

More about "Secretase"

Secretase, a group of proteolytic enzymes, plays a pivotal role in various biological processes, including the proteolytic processing of amyloid precursor protein (APP), which is implicated in the pathogenesis of Alzheimer's disease.
These enzymes, classified as α-secretase, β-secretase, and γ-secretase, cleave proteins and are crucial for understanding disease mechanisms and developing targeted therapies.
Secretase research is vital for advancing our understanding of disease pathways and exploring potential treatment options.
PubCompare.ai, a powerful AI-driven platform, optimizes this research by facilitating the comparison of Secretase-related protocols from literature, preprints, and patents.
This enables researchers to identify the best protocols, enhancing reproducibility and accuracy in their studies.
By leveraging the power of AI, PubCompare.ai helps researchers seamlessly navigate the vast landscape of Secretase research.
They can easily locate and compare the optimal Secretase-related protocols, including those involving DMSO, FBS, Lipofectamine 2000, β-secretase activity kit, DAPT, SensoLyte 520 TACE (α-secretase) activity assay kit, DMEM, Neurobasal medium, Laminin, and LY411575.
This streamlined approach empowers researchers to make informed decisions and advance their Secretase-focused investigations with greater efficiency and precision.
Experince the power of PubCompare.ai in your Secretase research journey, where you can effortlessly identify the most effective protocols and enhance the reproducibility and accuracy of your findings.